The partnership’s overall goal is to develop bioprinting technologies in order to advance regenerative medicine research.
The companies are determined to create an integrated bioprinting solution (or solutions) targeted specifically at printing tissues and scaffolds for regenerative medicine applications. Through the collaboration, 3D Systems and CollPlant will both have access to the former’s 3D printers and the latter’s BioInks, as well as new formulations of rhCollagen-based inks developed jointly by the companies.
The combination of printing technology and materials can be leveraged for their own products as well as by third parties. “3D Systems is excited to work with CollPlant to develop groundbreaking bioprinted tissue and scaffold technologies,” commented Chuck Hull, Co-Founder and CTO of 3D Systems. “We believe 3D printing to be a key technology for regenerative medicine, and […]
Scan Dimension, a 3D scanner developer with offices in the U.S. and Denmark, has announced an update to the software...